{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:18:35Z","timestamp":1792455515775,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T00:00:00Z","timestamp":1595980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T00:00:00Z","timestamp":1595980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s40618-020-01361-y","type":"journal-article","created":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T17:02:46Z","timestamp":1596042166000},"page":"421-429","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":110,"title":["Dysthyroid optic neuropathy: evaluation and management"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4861-7651","authenticated-orcid":false,"given":"P. J.","family":"Dolman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,29]]},"reference":[{"key":"1361_CR1","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/bjo.2006.094607","volume":"91","author":"D McKeag","year":"2007","unstructured":"McKeag D, Lane CM, Lazarus JH et al (2007) Clinical features of dysthyroid optic neuropathy: a European Group on Graves\u2019 Orbitopathy survey. Br J Ophthalmol 91:455\u2013458","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"1361_CR2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.beem.2011.11.007","volume":"26","author":"PJ Dolman","year":"2012","unstructured":"Dolman PJ (2012) Evaluating graves orbitopathy. Best Pract Res Clin Endocrinol Metab 26(3):229\u2013248","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"4 Suppl 1","key":"1361_CR3","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1097\/IOP.0000000000001146","volume":"34","author":"P Saeed","year":"2018","unstructured":"Saeed P, Tavakoli Rad S, Bisschop PHLT (2018) Dysthyroid optic neuropathy. Ophthalmic Plast Reconstr Surg 34(4 Suppl 1):S60\u2013S67","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"2","key":"1361_CR4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/17469899.2017.1276444","volume":"12","author":"AD Blandford","year":"2017","unstructured":"Blandford AD, Zhang D, Chundury RV, Perry JD (2017) Dysthyroid optic neuropathy: update on pathogenesis, diagnosis, and management. Expert Rev Ophthalmol 12(2):111\u2013121","journal-title":"Expert Rev Ophthalmol"},{"issue":"10","key":"1361_CR5","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1055\/s-0035-1555762","volume":"47","author":"RS Bahn","year":"2015","unstructured":"Bahn RS (2015) Current insights into the pathogenesis of Graves\u2019 ophthalmopathy. Horm Metab Res 47(10):773\u2013778","journal-title":"Horm Metab Res"},{"issue":"1","key":"1361_CR6","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/WNO.0000000000000890","volume":"40","author":"TJ Smith","year":"2020","unstructured":"Smith TJ (2020) Teprotumumab in thyroid-associated ophthalmopathy: rationale for therapeutic insulin-like growth factor-I receptor inhibition. J Neuroophthalmol 40(1):74\u201378","journal-title":"J Neuroophthalmol"},{"issue":"4S","key":"1361_CR7","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1097\/IOP.0000000000001150","volume":"34","author":"PJ Dolman","year":"2018","unstructured":"Dolman PJ (2018) Grading severity and activity in thyroid eye disease. Ophthal Plast Reconstr Surg 34(4S):S34\u2013S40","journal-title":"Ophthal Plast Reconstr Surg"},{"issue":"1","key":"1361_CR8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/IOP.0000000000000633","volume":"33","author":"MJ Davies","year":"2016","unstructured":"Davies MJ, Dolman PJ (2016) Levator muscle enlargement in thyroid eye disease-related upper eyelid retraction. Ophthalmic Plast Reconstr Surg 33(1):35\u201339","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"1361_CR9","unstructured":"Dolman PJ, Rootman J (2005) Predictors of disease severity in thyroid-related orbitopathy. (chap18) Orbital Disease. Present status and future challenges. Taylor and Francis"},{"key":"1361_CR10","first-page":"113","volume":"29","author":"FF Rundle","year":"1960","unstructured":"Rundle FF (1960) Ocular changes in Graves\u2019 disease. QJM 29:113\u2013126","journal-title":"QJM"},{"key":"1361_CR11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1530\/EJE-07-0666","volume":"158","author":"L Bartalena","year":"2008","unstructured":"Bartalena L et al (2008) Consensus statement of the European Group on Graves\u2019 orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol 158:273\u2013285","journal-title":"Eur J Endocrinol"},{"key":"1361_CR12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1365-2265.1997.2331047.x","volume":"47","author":"MP Mourits","year":"1997","unstructured":"Mourits MP, Prummel MF, Wiersinga WM et al (1997) Clinical activity score as a guide in the management of patients with Graves\u2019 Ophthalmopathy. Clin Endocrinol 47:9","journal-title":"Clin Endocrinol"},{"issue":"5","key":"1361_CR13","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/01.iop.0000235499.34867.85","volume":"22","author":"PJ Dolman","year":"2006","unstructured":"Dolman PJ, Rootman J (2006) VISA classification for Graves orbitopathy. Ophthalmic Plast Reconstr Surg 22(5):319\u2013324","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"1361_CR14","first-page":"41","volume":"65","author":"RM Day","year":"1967","unstructured":"Day RM, Carroll FD (1967) Corticosteroids in the treatment of optic nerve involvement associated with thyroid dysfunction. Trans Am Ophth Soc 65:41\u201351","journal-title":"Trans Am Ophth Soc"},{"issue":"5","key":"1361_CR15","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/archopht.1981.03930010807002","volume":"99","author":"JS Kennerdell","year":"1981","unstructured":"Kennerdell JS, Rosenbaum AE, El-Hoshy MH (1981) Apical optic nerve compression of dysthyroid optic neuropathy on computed tomography. Arch Ophthalmol 99(5):807\u2013809","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"1361_CR16","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bjo.84.6.600","volume":"84","author":"M Kazim","year":"2000","unstructured":"Kazim M, Trokel SL, Acaroglu G, Elliott A (2000) Reversal of dysthyroid optic neuropathy following orbital fat decompression. Br J Ophthalmol 84(6):600\u2013605","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"1361_CR17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/IOP.0000000000001501","volume":"36","author":"GE Rose","year":"2020","unstructured":"Rose GE, Vahdani K (2020) Optic nerve stretch is unlikely to be a significant causative factor in dysthyroid optic neuropathy. Ophthalmic Plast Reconstr Surg 36(2):157\u2013163","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"10","key":"1361_CR18","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/s41433-018-0144-x","volume":"32","author":"Y Wong","year":"2018","unstructured":"Wong Y, Dickinson J, Perros P et al (2018) A British Ophthalmological Surveillance Unit (BOSU) study into dysthyroid optic neuropathy in the United Kingdom. Eye 32(10):1555\u20131562","journal-title":"Eye"},{"key":"1361_CR19","unstructured":"Dolman PJ (2019) Dysthyroid optic neuropathy: evaluation and management. Hong Leong Professorship Special Lecture. IGOS 4th International Symposium, Singapore"},{"issue":"7","key":"1361_CR20","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1210\/jc.2015-4294","volume":"1010","author":"JJ Khong","year":"2016","unstructured":"Khong JJ, Finch S, De Silva C et al (2016) Risk factors for Graves\u2019 orbitopathy; the Australian Thyroid-Associated Orbitopathy Research (ATOR) Study. J Clin Endocrinol Metab 1010(7):2711\u20132720","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1361_CR21","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/bjo.83.4.463","volume":"83","author":"R Kalmann","year":"1999","unstructured":"Kalmann R, Mourits MP (1999) Diabetes mellitus: a risk factor in patients with Graves' orbitopathy. Br J Ophthalmol 83(4):463\u2013465","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"1361_CR22","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.ajo.2014.02.044","volume":"157","author":"PN Shams","year":"2014","unstructured":"Shams PN, Ma R, Pickles T, Rootman J (2014) Dolman PJ Reduced risk of compressive optic neuropathy using orbital radiotherapy in patients with active thyroid eye disease. Am J Ophthalmol 157(6):1299\u20131305","journal-title":"Am J Ophthalmol"},{"key":"1361_CR23","first-page":"19","volume-title":"Graves\u2019 orbitopathy: a multidisciplinary approach\u2014questions and answers","author":"AJ Dickinson","year":"2017","unstructured":"Dickinson AJ, Hintschich C (2017) In: Wiersinga WM, Kahaly GJ (eds) Graves\u2019 orbitopathy: a multidisciplinary approach\u2014questions and answers. Karger, Basel, pp 19\u201320"},{"issue":"10","key":"1361_CR24","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/archophthalmol.2011.276","volume":"29","author":"E Weis","year":"2011","unstructured":"Weis E, Heran MK, Jhamb A, Chan AK, Chiu JP, Hurley MC, Rootman J (2011) Clinical and soft-tissue computed tomographic predictors of dysthyroid optic neuropathy: refinement of the constellation of findings at presentation. Arch Ophthalmol 29(10):1332\u20131336","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"1361_CR25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/01676830.2017.1314510","volume":"36","author":"CJ Choi","year":"2017","unstructured":"Choi CJ, Oropesa S, Callahan AB, Glass LR et al (2017) Patterns of visual field changes in thyroid eye disease. Orbit 36(4):201\u2013207","journal-title":"Orbit"},{"issue":"1","key":"1361_CR26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/WCO.0000000000000636","volume":"32","author":"TW Lao","year":"2019","unstructured":"Lao TW, Rong SS, Ling AN, Brel\u00e9n ME et al (2019) Electrophysiological studies in thyroid associated orbitopathy: a systematic review. Curr Opin Neurol 32(1):115\u2013123","journal-title":"Curr Opin Neurol"},{"issue":"2","key":"1361_CR27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/17469899.2017.1276444","volume":"12","author":"JA Micieli","year":"2017","unstructured":"Micieli JA, Newman NJ, Biousse V (2017) The role of optical coherence tomography in the evaluation of compressive optic neuropathies. Expert Rev Ophthalmol 12(2):111\u2013121","journal-title":"Expert Rev Ophthalmol"},{"issue":"3","key":"1361_CR28","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00002341-200205000-00005","volume":"18","author":"JA Giaconi","year":"2002","unstructured":"Giaconi JA, Kazim M, Rho T et al (2002) CT scan evidence of dysthyroid optic neuropathy. Ophthalmic Plast Reconstr Surg 18(3):177\u2013182","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"1361_CR29","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/IOP.0000000000001224","volume":"35","author":"S Oropesa","year":"2018","unstructured":"Oropesa S, Dunbar KE, Godfrey KJ, Callahan AB, Campbell AA, Kazim M (2018) Predominant contribution of superior rectus-levator complex enlargement to optic neuropathy and inferior visual field defects in thyroid eye disease. Ophthalmic Plast Reconstr Surg 35:262\u2013265","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"4 Suppl 1","key":"1361_CR30","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1097\/IOP.0000000000001128","volume":"34","author":"AB Callahan","year":"2018","unstructured":"Callahan AB, Campbell AA, Oropesa S et al (2018) The Columbia thyroid eye disease-compressive optic neuropathy diagnostic formula. Ophthalmic Plast Reconstr Surg 34(4 Suppl 1):S68\u2013S71","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"7","key":"1361_CR31","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.18240\/ijo.2019.07.20","volume":"12","author":"LQ Zhao","year":"2019","unstructured":"Zhao LQ, Yu DY, Cheng JW (2019) Intravenous glucocorticoids therapy in the treatment of Graves\u2019 ophthalmopathy: a systematic review and meta-analysis. Int J Ophthalmol 12(7):1177\u20131186","journal-title":"Int J Ophthalmol"},{"issue":"12","key":"1361_CR32","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1210\/jc.2012-2389","volume":"97","author":"L Bartalena","year":"2012","unstructured":"Bartalena L, Krassas GE, Wiersinga W, Marcocci C et al (2012) (2012) European Group on Graves\u2019 Orbitopathy. Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves\u2019 orbitopathy. J Clin Endocrinol Metab 97(12):4454\u20134463","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1361_CR33","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/ICU.0b013e3283560b2b","volume":"23","author":"PJ Dolman","year":"2012","unstructured":"Dolman PJ, Rath S (2012) Orbital radiotherapy for thyroid eye disease. Curr Opin Ophthalmol 23(5):427\u2013432","journal-title":"Curr Opin Ophthalmol"},{"issue":"2","key":"1361_CR34","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/IOP.0000000000001003","volume":"34","author":"KG Gold","year":"2018","unstructured":"Gold KG, Scofield S, Isaacson SR, Stewart MW, Kazim M (2018) Orbital radiotherapy combined with corticosteroid treatment for thyroid eye disease-compressive optic neuropathy. Ophthalmic Plast Reconstr Surg 34(2):172\u2013177","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"1361_CR35","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1210\/jc.2014-3014","volume":"100","author":"M Salvi","year":"2015","unstructured":"Salvi M, Vannucchi G, Curro N et al (2015) Efficacy of B-cell targeted therapy with rituximab in patients with active moderate-severe Graves\u2019 orbitopathy: a randomized controlled study. J Clin Endocrinol Metab 100:402\u2013431","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1361_CR36","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1210\/jc.2014-2572","volume":"100","author":"MN Stan","year":"2015","unstructured":"Stan MN, Garrity JA, Carranza Leon BG, Prabin T et al (2015) Randomized controlled trial of rituximab in patients with Graves\u2019 orbitopathy. J Clin Endocrinol Metab 100(2):432\u2013441","journal-title":"J Clin Endocrinol Metab"},{"key":"1361_CR37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000443828","volume":"5","author":"L Bartalena","year":"2016","unstructured":"Bartalena L, Baldeschi L, Boboridis K, Eckstein A et al (2016) The 2016 European Thyroid Association\/European Group on Graves\u2019 orbitopathy guidelines for the management of graves' orbitopathy. Eur Thyroid J 5:9\u201326","journal-title":"Eur Thyroid J"},{"issue":"1","key":"1361_CR38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ophtha.2009.05.029","volume":"117","author":"D Khanna","year":"2010","unstructured":"Khanna D, Chong KK, Afifiyan NF, Hwang CJ et al (2010) Rituximab treatment of patients with severe, corticosteroid-resistant thyroid-associated ophthalmopathy. Ophthalmology 117(1):133\u2013139","journal-title":"Ophthalmology"},{"key":"1361_CR39","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ajo.2018.07.038","volume":"195","author":"JV Perez-Moreiras","year":"2018","unstructured":"Perez-Moreiras JV et al (2018) Efficacy of tocilizumab in patients with moderate-to-severe corticosteroid-resistant graves orbitopathy: a randomized clinical trial. Am J Ophthalmol 195:181\u2013190","journal-title":"Am J Ophthalmol"},{"key":"1361_CR40","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1910434","volume":"382","author":"RS Douglas","year":"2020","unstructured":"Douglas RS, Kahaly GJ, Patel A, Sile S et al (2020) Teprotumumab for the treatment of active thyroid eye disease. N Engl J Med 382:341\u2013352","journal-title":"N Engl J Med"},{"issue":"2","key":"1361_CR41","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41433-018-0259-0","volume":"33","author":"AA Tooley","year":"2019","unstructured":"Tooley AA, Godfrey KJ, Kazim M (2019) Evolution of thyroid eye disease decompression-dysthyroid optic neuropathy. Eye (Lond) 33(2):206\u2013211","journal-title":"Eye (Lond)"},{"key":"1361_CR42","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/eye.2017.260","volume":"32","author":"JM Jefferis","year":"2018","unstructured":"Jefferis JM, Jones RK, Currie ZI, Tan JH, Salvi SM (2018) Orbital decompression for thyroid eye disease: methods, outcomes, and complications. Eye 32:626\u2013636","journal-title":"Eye"},{"issue":"1","key":"1361_CR43","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/IOP.0b013e3181df6a87","volume":"27","author":"CH Choe","year":"2011","unstructured":"Choe CH, Cho R, Elner VM (2011) Comparison of lateral and medial orbital decompression for the treatment of compressive optic neuropathy in thyroid eye disease. Ophthalmic Plast Reconstr Surg 27(1):4\u201311","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"1361_CR44","first-page":"CD007630","volume":"12","author":"KG Boboridis","year":"2011","unstructured":"Boboridis KG, Bunce C (2011) Surgical orbital decompression for thyroid eye disease. Cochrane Database Syst Rev. 12:CD007630","journal-title":"Cochrane Database Syst Rev."},{"issue":"6","key":"1361_CR45","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/lary.20240","volume":"119","author":"EA Chu","year":"2009","unstructured":"Chu EA, Miller NR, Lane AP (2009) Selective endoscopic decompression of the orbital apex for dysthyroid optic neuropathy. Laryngoscope 119(6):1236\u20131240","journal-title":"Laryngoscope"},{"issue":"5","key":"1361_CR46","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.ajo.2005.12.010","volume":"141","author":"SL Liao","year":"2006","unstructured":"Liao SL, Chang TC, Lin LL (2006) Transcaruncular orbital decompression: an alternate procedure for Graves ophthalmopathy with compressive optic neuropathy. Am J Ophthalmol 141(5):810\u2013818","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"1361_CR47","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3341\/kjo.2012.26.2.73","volume":"26","author":"C Jeon","year":"2012","unstructured":"Jeon C, Shin JH, Woo KI, Kim YD (2012) Clinical profile and visual outcomes after treatment in patients with dysthyroid optic neuropathy. Korean J Ophthalmol 26(2):73\u201379","journal-title":"Korean J Ophthalmol"},{"issue":"2","key":"1361_CR48","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/01676830701563695","volume":"27","author":"J Badilla","year":"2008","unstructured":"Badilla J, Dolman PJ (2008) Intracranial hemorrhage complicating an orbital decompression. Orbit 27(2):143\u2013145","journal-title":"Orbit"},{"issue":"12","key":"1361_CR49","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1001\/archopht.125.12.1631","volume":"125","author":"J Badilla","year":"2007","unstructured":"Badilla J, Dolman PJ (2007) Cerebrospinal fluid leaks complicating orbital or oculoplastic surgery. Arch Ophthalmol 125(12):1631\u20131634","journal-title":"Arch Ophthalmol"},{"issue":"12","key":"1361_CR50","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1136\/bjophthalmol-2011-300487","volume":"95","author":"T Fayers","year":"2011","unstructured":"Fayers T, Dolman PJ (2011) Validity and reliability of the TED-QOL: a new three-item questionnaire to assess quality of life in thyroid eye disease. Br J Ophthalmol 95(12):1670\u20131674","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"1361_CR51","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1136\/bjo.82.7.773","volume":"82","author":"CB Terwee","year":"1998","unstructured":"Terwee CB, Gerding MN, Dekker FW, Prummel MF, Wiersinga WM (1998) Development of a disease specific quality of life questionnaire for patients with Graves\u2019 ophthalmopathy: the GO-QOL. Br J Ophthalmol 82(7):773\u2013779","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"1361_CR52","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/01676830.2016.1193542","volume":"35","author":"T Fayers","year":"2016","unstructured":"Fayers T, Fayers PM, Dolman PJ (2016) Sensitivity and responsiveness of the patient-reported TED-QOL to rehabilitative surgery in thyroid eye disease. Orbit 35(6):328\u2013333","journal-title":"Orbit"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01361-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-020-01361-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01361-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T23:21:04Z","timestamp":1627514464000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-020-01361-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,29]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["1361"],"URL":"https:\/\/doi.org\/10.1007\/s40618-020-01361-y","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,29]]},"assertion":[{"value":"16 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author confirms there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not required for review article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}